Rocket Pharmaceuticals
RCKT
RCKT
120 hedge funds and large institutions have $1.18B invested in Rocket Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
30% more funds holding
Funds holding: 92 → 120 (+28)
0.36% less ownership
Funds ownership: 94.74% → 94.38% (-0.36%)
10% less call options, than puts
Call options by funds: $765K | Put options by funds: $846K
Holders
120
Holding in Top 10
3
Calls
$765K
Puts
$846K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$9.94M | |
| 3 | +$8.89M | |
| 4 |
HM
HealthCor Management
New York
|
+$8.84M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.06M |
Top Sellers
| 1 | -$6.79M | |
| 2 | -$6.52M | |
| 3 | -$3.91M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$3.33M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.96M |